Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Checkpoint Inhibition in Anti-Tumor Responses
$97,500Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2022 · CA
Targeting Checkpoint Inhibition in Anti-Tumor Responses
$97,500Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R03 · FY2021 · CA
Cancer Immunology Research Program
$97,007Marcus W Bosenberg · Yale University · P30 · FY2025 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$96,972Barbara Burtness · Yale University · P50 · FY2024 · DE
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$96,857Timothy R Donahue · University Of California Los Angeles · R01 · FY2022 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$96,743Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$96,699Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2020 · CA
Controlled Antigen Delivery for Prophylactic Cancer Vaccination
$96,541Brett Pogostin · Massachusetts Institute Of Technology · K00 · FY2024 · CA
Genome Integrity Through the Cell Cycle in Homeostasis and Cancer
$96,396Zachary Kenneth Mirman · Brigham And Women'S Hospital · K00 · FY2023 · CA
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
$96,390Camila Robles-Oteiza · Dana-Farber Cancer Inst · K00 · FY2024 · CA
Musculoskeletal Pain Among Breast Cancer Survivors: Through Bio-behavioral and Imaging Lenses
$96,180Yehui Zhu · Massachusetts General Hospital · K00 · FY2021 · CA
Functional Analysis of p53 Polymorphic Variants
$95,992Maureen E Murphy · Wistar Institute · R01 · FY2025 · CA
Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levels
$95,531Pui-Yan Victor Ma · Brigham And Women'S Hospital · K00 · FY2021 · CA
Understanding IDH mutant gliomas
$95,423Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Macrophages and fibroblasts in the progression of lung cancer
$95,347Michelle Kayoko Ozaki · Stanford University · K00 · FY2025 · CA
Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
$95,308Gurkan Mollaoglu · Icahn School Of Medicine At Mount Sinai · K00 · FY2021 · CA
Profiling and leveraging bystander T cells within the tumor microenvironment
$94,701Nicholas Joseph Maurice · University Of Minnesota · K00 · FY2024 · CA
Regulation of CD4+ T Cell Responses During Chronic Viral Infection
$94,659Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2021 · AI
Tumor Suppressor Qualities and Mechanisms of LZAP Activity
$94,432Wendell G Yarbrough · Yale University · R01 · FY2012 · DE
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$94,385Melody A Swartz · University Of Chicago · R01 · FY2024 · CA
Tumor Intrinsic Regulation of Immune Evasion Pathways in Breast Cancer
$94,380Sheera Rosenbaum · University Of Colorado Denver · K00 · FY2023 · CA
Epigenetic activation of the interferon response to sensitize cancers to immune therapy
$94,151Katherine B Chiappinelli · Johns Hopkins University · K99 · FY2016 · CA
USING DEEP MUTATIONAL SCANNING TO CHARACTERIZE TUMOR-IMMUNE INTERACTIONS
$94,091Noah Greenwald · University Of California, San Francisco · K00 · FY2025 · CA
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer
$93,878Leigh Ellis · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Consolidated Basic Cancer Research Program
$93,642Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA